GIBBS MICHAEL TERRENCE (General Counsel) sold 3.5% of their position (239.00 shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $114.96 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2023ACC: 0000950170-23-012031
Officer· General Counsel
Since Jul 2018
-239.00
Net shares
Net seller
$114.96
Total sold
1
Open market trades
0B · 1S
1
Total transactions
239.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−239.00
Price / share
$0.48
Trade value
$114.96
% of position
3.5%
3/28/2023
6.85K→6.61K
Total
Net shares
−239.00
Net value
-$114.96
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/28/2023 | S · Sale | −239.00 | $0.48 | $114.96 | 3.5% | 6.85K | 6.61K |
| Total | −239.00 | -$114.96 | ||||||
Derivative Transactions0
No derivative transactions reported